Itch Severity News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Itch Severity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Itch Severity Today - Breaking & Trending Today

Rilzabrutinib Reduces Itch, Hives in Chronic Spontaneous Urticaria in Phase 2 Trial

Published: February 24, 2024

Rilzabrutinib, an oral BTK inhibitor, demonstrates efficacy in reducing itch and disease activity among patients with chronic spontaneous urticaria in phase 2 dose-ranging trial at AAAAI 2024.

Source: hcplive.com

Related Topics:

United StatesMarcus MaurerAmerican Academy Of AllergyInstitute Of AllergologyCharite BerlinAnnual MeetingItch SeverityChronic Spontaneous UrticariaAaaai 2024 Late BreakerCsu TreatmentsChronic Spontaneous Urticaria Csu Oral Btk InhibitorsBtk Inhibitor